Cutler Group LP Eli Lilly & CO Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Cutler Group LP holds 1,100 shares of LLY stock, worth $1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,100

Previous 809 35.97%

Holding current value

$1 Million

Previous $471,000 52.65%

% of portfolio

0.07%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $190,118 - $224,125	-362 Reduced 30.91%	809 $471,000
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $100,415 - $138,438	-231 Reduced 16.48%	1,171 $628,000
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $491,737 - $657,509	1,402 New	1,402 $657,000
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $245,342 - $285,873	763 Added 14.18%	6,143 $2.25 Million
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $3.3 Million - $3.76 Million	-11,116 Reduced 67.39%	5,380 $1.74 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $4.53 Million - $5.32 Million	16,253 Added 6688.48%	16,496 $5.35 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $5.62 Million - $6.98 Million	-23,927 Reduced 98.99%	243 $69,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $5.33 Million - $6.61 Million	23,696 Added 4999.16%	24,170 $6.68 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $60,718 - $74,722	274 Added 137.0%	474 $109,000
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $51,981 - $61,186	-467 Reduced 70.01%	200 $25,000
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $54,653 - $58,622	667	667 $56,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account